Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 20/20 | 1.00 |
| ▸ | DDB1 | Q16531 | 19/20 | 1.00 |
| ▸ | BRD4 | O60885 | 14/20 | 1.00 |
| ▸ | TRIM24 | O15164 | 1/20 | 1.00 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 1.00 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.99 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.99 |
| ▸ | BET1 | O15155 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23789740 | 1.00 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL17859001 | 1.00 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL19556879 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL17859034 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL30146573 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL17553399 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL19556839 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL19556892 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL19556887 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 | |
| SCHEMBL29566239 | 0.99 | CRBN (1.00) | CRBNDDB1BRD4TRIM24TRIM33 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059442-A1 | MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS | REMOTE EPIGENETICS INC. (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2025029640-A1 | TARGETING LIPOSOME FOR PROTEIN DEGRADER DELIVERY | SIGMA-ALDRICH CO. LLC (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024229271-A1 | NANOPARTICLE-BASED THERANOSTIC PLATFORM FOR DIAGNOSIS AND TREATMENT OF SENESCENCE-RELATED PATHOLOGIES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-11-07 | — | — | WO | claimed |
| CN-118512610-A | Novel carrier PROTACs lipid ultrasonic microbubbles and preparation method and application thereof | 重庆医科大学附属第二医院 | 2024-08-20 | — | — | CN | claimed |
| WO-2024152648-A1 | USE OF BET PROTEIN DEGRADATION AGENT IN PREVENTION AND TREATMENT OF DISEASES RELATED TO RETINAL DEGENERATIVE CHANGE | 中山大学中山眼科中心 | 2024-07-25 | — | — | WO | claimed |
| CN-117695219-A | X-ray radiation responsive proteolytic targeting chimeric nano micelle and preparation method and application thereof | 中国药科大学 | 2024-03-15 | — | — | CN | claimed |
| EP-4314018-A1 | METHODS AND COMPOSITIONS FOR HIGH-POTENCY POLYPEPTIDE-BASED PROTEIN INHIBITION | Baylor College of Medicine (US) | 2024-02-07 | — | — | EP | claimed |
| US-20230355711-A1 | VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2023-11-09 | — | — | US | claimed |
| CN-116585322-B | Use of BET protein degradation agent in preventing and treating diseases related to retinal degenerative changes | 中山大学中山眼科中心 | 2023-10-13 | — | — | CN | claimed |
| EP-4243805-A1 | COMBINATION THERAPIES FOR TREATING CORONAVIRUS INFECTION | Gbiotech S.À.R.L. (CH) | 2023-09-20 | — | — | EP | claimed |
| US-20230210902-A1 | SARS-COV-2-SPECIFIC T CELLS | NATIONAL INSTITUTES OF HEALTH | 2023-07-06 | — | — | US | claimed |
| EP-4149496-A1 | SARS-COV-2-SPECIFIC T CELLS | Board of Regents, The University of Texas System (US) | 2023-03-22 | — | — | EP | claimed |
| US-20220401553-A1 | PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS INFECTIONS | AICURIS GMBH & CO. KG (DE) | 2022-12-22 | — | — | US | claimed |
| WO-2022213076-A1 | METHODS AND COMPOSITIONS FOR HIGH-POTENCY POLYPEPTIDE-BASED PROTEIN INHIBITION | BAYLOR COLLEGE OF MEDICINE (US) | 2022-10-06 | — | — | WO | claimed |
| US-20220288051-A1 | METHODS FOR TREATING CANCER USING SERIAL ADMINISTRATION OF E3 UBIQUITIN LIGASE DEGRADERS | DANA-FARBER CANCER INSTITUTE, INC. | 2022-09-15 | — | — | US | claimed |
| EP-3906970-B1 | PARAPOXVIRUS FOR CONDITIONING AND TREATMENT OF CORONAVIRUS INFECTIONS | AICURIS GMBH & CO KG (DE) | 2022-07-06 | — | — | EP | claimed |
| US-20220193204-A1 | USES OF A2 DOMAIN OF VON WILLEBRAND FACTOR | BAYLOR COLLEGE OF MEDICINE (US) | 2022-06-23 | — | — | US | claimed |
| EP-4010081-A1 | COMBINATION THERAPY FOR TREATMENT OF CANCER | Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center (US) | 2022-06-15 | — | — | EP | claimed |
| EP-3969036-A1 | USES OF A2 DOMAIN OF VON WILLEBRAND FACTOR | Baylor College of Medicine (US) | 2022-03-23 | — | — | EP | claimed |
| WO-2022029334-A1 | COMBINATION THERAPIES FOR TREATING CORONAVIRUS INFECTION | GBIOTECH S.À.R.L. (CH) | 2022-02-10 | — | — | WO | claimed |